产品编号：L465900
产品规格：100mg
产品价格：面议
| 标准品编号: | L465900 |
| 名称: | Linagliptin |
| 别名: | 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione; BI 1356; BI 1356BS; ONDERO; |
| CAS号: | 668270-12-0 |
| 分子式: | C₂₅H₂₈N₈O₂ |
| 外观: | 白色至Orange Solid |
| 熔点: | 187-190ºC |
| 分子量: | 472.54 |
| 储存: | 冰箱 |
| 溶解度: | Chloroform (Sparingly), DMSO (Slightly), Methanol (Slightly) |
| 种类: | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. |
| 参考文献 | |
